BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 16274727)

  • 1. Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?
    Squitieri F; Frati L; Ciarmiello A; Lastoria S; Quarrell O
    Mech Ageing Dev; 2006 Feb; 127(2):208-12. PubMed ID: 16274727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Juvenile onset Huntington's disease--clinical and research perspectives.
    Nance MA; Myers RH
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):153-7. PubMed ID: 11553930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients.
    Sathasivam K; Woodman B; Mahal A; Bertaux F; Wanker EE; Shima DT; Bates GP
    Hum Mol Genet; 2001 Oct; 10(21):2425-35. PubMed ID: 11689489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease.
    Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC
    Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intergeneration CAG expansion and contraction in a Chinese HD family.
    Tang Y; Wang Y; Yang P; Liu Y; Wang B; Podolsky R; McIndoe R; Wang CY
    Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):242-4. PubMed ID: 16526033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile onset Huntington disease resulting from a very large maternal expansion.
    Nahhas FA; Garbern J; Krajewski KM; Roa BB; Feldman GL
    Am J Med Genet A; 2005 Sep; 137A(3):328-31. PubMed ID: 16096998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
    Kennedy L; Shelbourne PF
    Hum Mol Genet; 2000 Oct; 9(17):2539-44. PubMed ID: 11030759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
    Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
    Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XL PCR for the detection of large trinucleotide expansions in juvenile Huntington's disease.
    Milunsky JM; Maher TA; Loose BA; Darras BT; Ito M
    Clin Genet; 2003 Jul; 64(1):70-3. PubMed ID: 12791042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
    Li SH; Li XJ
    Trends Genet; 2004 Mar; 20(3):146-54. PubMed ID: 15036808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of the miniature pig Huntington's disease gene homolog: evidence for conservation and polymorphism in the CAG triplet repeat.
    Matsuyama N; Hadano S; Onoe K; Osuga H; Showguchi-Miyata J; Gondo Y; Ikeda JE
    Genomics; 2000 Oct; 69(1):72-85. PubMed ID: 11013077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does the Huntington's disease mutation damage cells?
    Rubinsztein DC
    Sci Aging Knowledge Environ; 2003 Sep; 2003(37):PE26. PubMed ID: 13679594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and neuropathology of Huntington's disease.
    Reiner A; Dragatsis I; Dietrich P
    Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease.
    Weiss A; Klein C; Woodman B; Sathasivam K; Bibel M; Régulier E; Bates GP; Paganetti P
    J Neurochem; 2008 Feb; 104(3):846-58. PubMed ID: 17986219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive blinking as an initial manifestation of juvenile Huntington's disease.
    Xing S; Chen L; Chen X; Pei Z; Zeng J; Li J
    Neurol Sci; 2008 Sep; 29(4):275-7. PubMed ID: 18810605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamine pathogenesis.
    Ross CA; Wood JD; Schilling G; Peters MF; Nucifora FC; Cooper JK; Sharp AH; Margolis RL; Borchelt DR
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1005-11. PubMed ID: 10434299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.